LOGIN  |  REGISTER
Surmodics

List of Medical Device Stocks

Company
Last Trade
Change
Volume
Shares Out
Market Cap
US$ 103.95
-0.28 -0.27
3.90M
1.74B
US$ 180.870B
US$ 404.85
6.46 1.62
1.07M
354.71M
US$ 143.600B
US$ 335.54
5.42 1.64
1.20M
380.95M
US$ 127.820B
US$ 75.63
1.25 1.68
4.66M
1.47B
US$ 111.180B
US$ 82.29
0.91 1.12
8.57M
1.33B
US$ 109.450B
US$ 228.79
-1.56 -0.68
1.30M
289.01M
US$ 66.120B
US$ 87.98
0.52 0.59
1.71M
602.60M
US$ 53.020B
US$ 89.43
-0.33 -0.37
628,248
493.24M
US$ 44.110B
US$ 213.26
1.68 0.79
523,543
146.91M
US$ 31.330B
US$ 331.66
3.07 0.93
375,016
72.84M
US$ 24.160B
US$ 116.41
0.56 0.48
1.04M
205.73M
US$ 23.950B
US$ 229.17
2.36 1.04
496,476
98.81M
US$ 22.640B
US$ 94.89
0.45 0.48
631,617
198.76M
US$ 18.860B
US$ 33.90
-0.10 -0.29
4.84M
509.58M
US$ 17.270B
US$ 73.80
-0.19 -0.26
1.26M
233.38M
US$ 17.220B
US$ 180.07
9.28 5.43
667,310
70.04M
US$ 12.610B
US$ 334.15
0.05 0.01
1.19M
37.54M
US$ 12.540B
US$ 77.25
0.55 0.72
762,764
145.34M
US$ 11.230B
US$ 24.87
0.22 0.89
1.30M
437.17M
US$ 10.870B
US$ 206.35
-0.19 -0.09
404,179
47.10M
US$ 9.720B
US$ 158.16
-0.62 -0.39
362,381
55.88M
US$ 8.840B
US$ 193.66
2.97 1.56
185,195
38.76M
US$ 7.510B
US$ 65.82
0.43 0.66
622,597
112.63M
US$ 7.410B
US$ 127.00
2.25 1.80
598,977
53.09M
US$ 6.740B
US$ 287.21
-3.04 -1.05
136,296
23.45M
US$ 6.740B
US$ 108.89
1.45 1.35
391,084
50.37M
US$ 5.480B
US$ 15.02
0.31 2.11
258,198
351.48M
US$ 5.280B
US$ 81.92
1.02 1.26
213,818
58.11M
US$ 4.760B
US$ 158.72
3.90 2.52
368,109
29.71M
US$ 4.720B
US$ 140.29
2.76 2.01
539,647
32.94M
US$ 4.620B
US$ 88.34
-0.30 -0.34
632,641
50.79M
US$ 4.490B
US$ 122.63
0.80 0.66
165,728
33.50M
US$ 4.110B
US$ 66.90
0.17 0.25
685,196
51.42M
US$ 3.440B
US$ 67.22
-0.11 -0.16
284,108
51.02M
US$ 3.430B
US$ 51.73
2.05 4.13
1.01M
64.59M
US$ 3.340B
US$ 59.60
0.22 0.37
394,351
54.15M
US$ 3.230B
US$ 49.95
2.51 5.29
1.09M
58.14M
US$ 2.900B
US$ 88.94
0.90 1.02
268,939
31.10M
US$ 2.770B
US$ 50.94
0.67 1.33
361,541
53.92M
US$ 2.750B
US$ 23.15
0.84 3.77
791,576
107.61M
US$ 2.490B
US$ 101.68
-2.61 -2.50
214,263
24.37M
US$ 2.480B
US$ 61.15
0.56 0.92
298,152
39.25M
US$ 2.400B
US$ 74.07
0.98 1.34
231,546
30.80M
US$ 2.280B
US$ 28.31
-0.20 -0.70
814,383
78.80M
US$ 2.230B
US$ 41.16
-1.01 -2.40
277,436
49.13M
US$ 2.020B
US$ 79.75
0.17 0.21
56,766
22.45M
US$ 1.790B
US$ 17.25
0.45 2.68
1.21M
99.10M
US$ 1.710B
US$ 18.48
0.03 0.16
760,421
84.62M
US$ 1.560B
US$ 53.54
0.44 0.83
199,429
27.51M
US$ 1.470B
US$ 10.12
0.02 0.20
1.31M
139.88M
US$ 1.420B
US$ 10.07
0.45 4.68
641,642
133.20M
US$ 1.340B
US$ 7.75
-0.02 -0.26
659,447
147.60M
US$ 1.140B
US$ 23.19
0.73 3.25
922,032
48.38M
US$ 1.120B
US$ 21.72
0.63 2.99
226,234
46.03M
US$ 999.770M
US$ 23.78
0.13 0.55
112,996
41.73M
US$ 992.340M
US$ 19.97
-0.18 -0.89
412,416
49.48M
US$ 988.120M
US$ 1.49
-0.02 -1.32
6.74M
622.63M
US$ 927.720M
US$ 19.96
0.11 0.55
101,408
45.90M
US$ 916.160M
US$ 21.93
0.40 1.86
363,776
39.44M
US$ 864.920M
US$ 462.93
-1.07 -0.23
28,011
1.76M
US$ 814.760M
US$ 5.96
0.04 0.68
316,912
131.27M
US$ 782.370M
US$ 32.54
0.81 2.55
96,047
23.83M
US$ 775.430M
US$ 7.82
0.15 1.96
309,517
82.95M
US$ 648.670M
US$ 16.42
-0.14 -0.85
202,557
38.27M
US$ 628.390M
US$ 11.37
-0.58 -4.85
208,482
55.23M
US$ 627.970M
US$ 14.79
0.11 0.75
242,966
40.86M
US$ 604.320M
US$ 14.89
0.02 0.13
185,230
37.53M
US$ 558.820M
US$ 13.55
0.14 1.04
199,350
41.20M
US$ 558.260M
US$ 42.38
0.16 0.38
27,843
12.66M
US$ 536.530M
US$ 8.43
-0.16 -1.86
919,959
57.79M
US$ 487.170M
US$ 4.54
0.00 0.00
245,736
104.54M
US$ 474.610M
US$ 16.79
0.07 0.42
112,692
27.29M
US$ 458.200M
US$ 2.74
-0.07 -2.49
105,040
156.55M
US$ 428.950M
US$ 6.37
0.04 0.63
238,013
63.83M
US$ 406.600M
US$ 4.85
-0.07 -1.42
507,809
73.96M
US$ 358.710M
US$ 9.39
0.00 0.00
406,454
36.73M
US$ 344.890M
US$ 10.52
0.23 2.24
88,107
31.78M
US$ 334.330M
US$ 5.16
0.12 2.38
743,072
62.01M
US$ 319.970M
US$ 8.07
-0.31 -3.70
260,862
38.82M
US$ 313.280M
US$ 12.86
0.08 0.63
244,639
23.76M
US$ 305.550M
US$ 5.57
0.29 5.49
65,049
49.76M
US$ 277.160M
US$ 7.06
0.16 2.32
222,625
38.82M
US$ 274.070M
US$ 6.27
0.16 2.62
106,537
43.70M
US$ 274.000M
US$ 31.00
2.20 7.64
23,421
8.63M
US$ 267.530M
US$ 6.17
0.05 0.82
212,918
40.05M
US$ 247.110M
US$ 8.50
0.17 2.04
154,840
28.68M
US$ 243.780M
US$ 67.01
-0.06 -0.09
16,738
3.53M
US$ 236.550M
US$ 0.44
-0.0051 -1.14
1.07M
530.89M
US$ 235.720M
US$ 6.12
0.21 3.55
10,630
37.10M
US$ 227.050M
US$ 6.48
-0.09 -1.37
103,517
34.49M
US$ 223.500M
US$ 7.53
-0.07 -0.92
92,405
28.77M
US$ 216.640M
US$ 7.78
-0.07 -0.89
131,571
27.79M
US$ 216.210M
US$ 8.10
-0.12 -1.46
153,887
25.80M
US$ 208.980M
US$ 8.81
0.56 6.79
209,467
23.58M
US$ 207.740M
US$ 7.56
-1.98 -20.75
352,376
27.16M
US$ 205.330M
US$ 3.87
-0.12 -3.01
1.03M
51.72M
US$ 200.160M
US$ 1.01
-0.02 -1.94
975,557
184.28M
US$ 186.120M
US$ 7.35
-0.07 -0.94
25,875
24.43M
US$ 179.560M
US$ 23.32
0.38 1.66
38,948
7.07M
US$ 164.870M
US$ 1.98
-0.04 -1.98
274,678
82.64M
US$ 163.630M
US$ 7.45
-0.37 -4.73
318,802
21.60M
US$ 160.920M
US$ 7.11
0.19 2.75
53,669
21.30M
US$ 151.440M
US$ 1.51
0.02 1.34
878,332
99.24M
US$ 149.850M
US$ 5.85
-0.04 -0.68
52,477
24.66M
US$ 144.260M
US$ 16.58
0.04 0.24
12,744
8.66M
US$ 143.580M
US$ 3.16
-0.02 -0.63
335,354
43.43M
US$ 137.240M
US$ 3.19
0.06 1.92
443,641
42.57M
US$ 135.800M
US$ 3.83
0.00 0.00
141,275
28.81M
US$ 110.340M
US$ 2.20
0.01 0.46
1.92M
45.76M
US$ 100.670M
US$ 6.10
0.18 3.04
305,031
16.39M
US$ 99.980M
US$ 15.34
0.03 0.20
36,243
6.33M
US$ 97.100M
US$ 1.97
0.03 1.29
446,981
49.39M
US$ 97.050M
US$ 0.74
-0.03 -3.60
84,457
130.22M
US$ 96.360M
US$ 1.67
0.04 2.45
128,195
54.98M
US$ 91.820M
US$ 5.40
0.05 0.93
61,770
16.65M
US$ 89.910M
US$ 1.63
0.09 5.84
52,176
47.95M
US$ 78.160M
US$ 19.74
0.22 1.13
2,383
3.42M
US$ 67.510M
US$ 5.01
0.08 1.62
40,172
13.33M
US$ 66.780M
US$ 0.24
-0.0036 -1.47
1.01M
272.33M
US$ 65.580M
US$ 3.25
0.00 0.00
4,858
20.04M
US$ 65.130M
US$ 2.01
0.03 1.52
73,415
31.67M
US$ 63.660M
US$ 3.50
0.00 0.00
0
17.86M
US$ 62.510M
US$ 2.51
-0.01 -0.52
7,379
24.93M
US$ 62.500M
US$ 0.15
0.0002 0.14
943,267
401.03M
US$ 58.950M
US$ 0.75
-0.02 -2.59
32,675
77.23M
US$ 57.910M
US$ 1.60
0.00 0.00
9,094
34.64M
US$ 55.420M
US$ 2.76
-0.29 -9.51
58,715
19.60M
US$ 54.100M
US$ 2.57
0.00 0.00
0
20.76M
US$ 53.350M
US$ 1.11
0.01 0.91
318,668
45.90M
US$ 50.720M
US$ 0.88
0.02 2.09
18,865
56.95M
US$ 50.060M
US$ 0.90
-0.03 -3.57
32,536
54.31M
US$ 48.880M
US$ 1.57
0.03 1.95
18,347
30.99M
US$ 48.650M
US$ 0.92
-0.01 -1.52
123,145
52.11M
US$ 47.730M
US$ 4.17
0.03 0.72
9,926
11.40M
US$ 47.540M
US$ 1.03
-0.01 -0.96
88,227
45.73M
US$ 47.100M
C$ 0.46
0.02 4.55
28,274
101.40M
C$ 46.640M
US$ 0.35
-0.02 -6.19
264,581
127.60M
US$ 44.690M
US$ 0.45
-0.66 -59.51
248,900
98.27M
US$ 44.320M
US$ 2.06
0.00 0.00
370,255
20.07M
US$ 41.340M
US$ 6.84
-0.06 -0.87
4,169
6.01M
US$ 41.110M
US$ 2.50
0.01 0.40
25,976
16.25M
US$ 40.620M
C$ 0.16
0.00 0.00
64,500
239.30M
C$ 38.290M
US$ 2.19
0.05 2.34
97,093
17.36M
US$ 38.020M
C$ 0.30
-0.005 -1.67
29,625
118.47M
C$ 34.950M
C$ 0.22
-0.005 -2.22
41,000
156.82M
C$ 34.500M
C$ 0.53
-0.02 -3.64
19,500
65.05M
C$ 34.480M
US$ 3.65
-0.05 -1.35
18,412
9.05M
US$ 33.030M
US$ 0.82
0.00 0.00
48,067
37.55M
US$ 30.790M
US$ 1.28
0.04 3.23
316,775
22.22M
US$ 28.440M
US$ 1.62
-0.01 -0.61
160,494
17.48M
US$ 28.320M
US$ 0.38
0.01 2.97
47,991
74.07M
US$ 28.220M
US$ 0.94
0.0072 0.77
55,128
29.94M
US$ 28.160M
US$ 1.06
-0.03 -2.75
459,839
25.93M
US$ 27.490M
US$ 2.19
-0.01 -0.48
9,798
10.54M
US$ 23.080M
US$ 1.26
-0.04 -3.08
86,166
18.17M
US$ 22.890M
US$ 0.02
0.00 0.00
0
1.14B
US$ 21.200M
US$ 1.73
0.10 6.13
81,493
11.98M
US$ 20.730M
C$ 0.10
0.00 0.00
75,450
194.28M
C$ 19.430M
C$ 0.26
0.00 0.00
0
69.23M
C$ 17.650M
US$ 0.65
0.02 3.14
48,619
25.46M
US$ 16.540M
US$ 9.00
-0.14 -1.53
9,196
1.82M
US$ 16.380M
US$ 1.73
0.08 4.85
43,773
9.43M
US$ 16.310M
C$ 0.08
0.00 0.00
0
188.08M
C$ 15.050M
US$ 1.02
-0.03 -2.95
49,614
14.40M
US$ 14.690M
US$ 2.35
0.05 2.17
3,872
6.23M
US$ 14.640M
US$ 0.39
0.02 4.05
50,850
35.06M
US$ 13.500M
US$ 0.61
-0.04 -6.15
4,209
18.63M
US$ 11.360M
US$ 1.19
-0.02 -1.65
39,118
9.31M
US$ 11.080M
US$ 0.63
-0.02 -2.64
28,043
16.82M
US$ 10.530M
US$ 0.47
0.00 0.00
0
17.39M
US$ 8.170M
US$ 3.96
0.11 2.86
3,846
1.99M
US$ 7.880M
US$ 1.01
-0.05 -4.72
64,972
7.44M
US$ 7.510M
US$ 2.31
0.005 0.22
53,540
3.12M
US$ 7.210M
US$ 1.57
-0.05 -3.06
33,070
4.10M
US$ 6.430M
US$ 2.10
0.01 0.48
18,614
2.98M
US$ 6.260M
US$ 0.08
0.00 0.00
0
73.90M
US$ 6.060M
US$ 0.09
-0.14 -62.91
30,500
70.46M
US$ 6.010M
US$ 3.45
-0.09 -2.54
21,822
1.67M
US$ 5.760M
US$ 0.86
-0.41 -32.28
23,587
6.22M
US$ 5.350M
US$ 0.62
-0.03 -4.61
7,481
7.95M
US$ 4.920M
US$ 0.39
0.00 0.00
0
11.77M
US$ 4.560M
US$ 0.25
0.03 13.27
5.47M
18.05M
US$ 4.500M
US$ 0.19
0.008 4.44
475,626
23.46M
US$ 4.410M
US$ 2.60
-0.23 -7.96
27,139
1.59M
US$ 4.130M
US$ 6.20
0.67 12.12
247,410
655,616
US$ 4.060M
US$ 0.53
-0.0092 -1.72
35,599
7.57M
US$ 3.980M
US$ 0.04
0.0075 23.08
58,347
96.36M
US$ 3.850M
C$ 0.02
0.00 0.00
481,061
246.29M
C$ 3.690M
US$ 0.89
0.02 2.29
39,571
3.80M
US$ 3.380M
US$ 0.53
-0.03 -6.00
7,987
6.36M
US$ 3.380M
US$ 0.21
0.02 12.73
7.02M
15.67M
US$ 3.360M
US$ 0.74
-0.0051 -0.68
6,314
3.73M
US$ 2.770M
US$ 0.41
0.02 5.13
8,013
5.31M
US$ 2.180M
US$ 0.78
0.03 4.16
28,923
2.78M
US$ 2.160M
US$ 1.24
-0.04 -3.12
80,488
1.59M
US$ 1.970M
US$ 0.31
0.00 0.00
0
5.24M
US$ 1.600M
US$ 0.05
-0.06 -52.52
11,400
28.90M
US$ 1.440M
US$ 0.05
-0.04 -49.33
118,619
29.72M
US$ 1.360M
US$ 1.50
-0.01 -0.66
21,433
879,176
US$ 1.320M
US$ 0.49
-0.008 -1.61
23,172
2.69M
US$ 1.320M
US$ 0.12
0.00 0.00
0
10.22M
US$ 1.180M
US$ 0.42
0.01 2.44
594,938
2.63M
US$ 1.100M
US$ 0.40
-0.0051 -1.24
209,561
1.47M
US$ 595K
US$ 0.001
0.0001 11.11
19.12M
507.29M
US$ 507K
US$ 4.72
0.00 0.00
44,633
-
US$ -
C$ 1.40
0.00 0.00
20,796
-
C$ -
C$ 0.16
0.00 0.00
17,857
-
C$ -

Latest News From Medical Device Stocks


Ocumetics Technology Announces Completion of First Tranche of Debenture Private Placement for Net Proceeds of CA$2.82 Million

Calgary, Alberta – May 24, 2024 - TheNewswire.  Ocumetics Technology Corp. (“Ocumetics” or the “Corporation”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that it has completed the first tranche of the private placement of debentures previously announced by the Corporation on May 15, 2024. The Corporation has issued secured convertible debentures having an aggregate face value principal amount of $3,000,000 (the “Principal”).  The debentures were... Read more


Stereotaxis Receives CE Mark Recertification Under EU’s MDR Regulatory Framework

ST. LOUIS, May 24, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has received CE Mark recertification under the European Union’s new Medical Device Regulation (MDR) regulatory framework. The recertification under MDR covers all Stereotaxis devices currently available in Europe. MDR (Regulation (EU) 2017/745) replaces the former European Medical... Read more


Stevanato to Present at Upcoming Investor Conferences

PIOMBINO DESE, Italy / May 23, 2024 / Business Wire / Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in two upcoming investor conferences. The Company will present at the William Blair Growth Stock Conference in Chicago on Tuesday, June 4, 2024 at 4:00 p.m. (CT), and at the Jefferies Healthcare... Read more


Penumbra to Present at the William Blair Growth Stock Conference

ALAMEDA, Calif., May 23, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the William Blair Growth Stock Conference on Thursday, June 6, 2024. Event: William Blair Growth Stock Conference   Date: Thursday, June 6, 2024   Time: 12:20pm ET/9:20am PT   A webcast of the presentation can be accessed on the "Events and Presentations" section... Read more


Baxter to Present at Jefferies 2024 Global Healthcare Conference

DEERFIELD, Ill. / May 23, 2024 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies 2024 Global Healthcare Conference on Wednesday, June 5, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 9:30 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through Monday, December 2, 2024. About Baxter Every day, millions... Read more


Tandem Diabetes Care Announces Upcoming Conference Presentation

SAN DIEGO / May 23, 2024 / Business Wire / Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 8:00am Eastern Time (5:00am Pacific Time). The Company update presentation will be webcast live, and an archive recording will be available for 30 days. The link to the live webcast and archive... Read more


Harvard Bioscience to Present at the Jefferies Global Healthcare Conference on June 5, 2024

HOLLISTON, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the Jefferies Global Healthcare Conference at the Marriott Marquis in New York City on June 5, 2024. The Company’s presentation will be 2:00-2:25 PM ET on June 5th. The presentation will be webcast live and can be accessed through... Read more


Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy

Among 26 ResMed-supported abstracts, these were the highlights: New findings show positive airway pressure (PAP) therapy reduced risks of death and hospitalization for patients with obstructive sleep apnea (OSA) Prevalence of OSA in the United States expected to increase 26.7% in men and women aged 30 –70 Real-world trends of glucagon-like peptide-1 (GLP-1) receptor agonist and PAP therapy use show patients who were adherent to their GLP-1 medication had higher levels... Read more


LivaNova to Present at the Goldman Sachs Healthcare Conference

LONDON / May 23, 2024 / Business Wire / LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present in a fireside chat at the Goldman Sachs Healthcare Conference in Miami, Florida. The presentation will take place at 1:20 p.m. Eastern Time on Monday, June 10. The discussion will be available to all interested parties who register to attend the webcast, which is accessible via www.li... Read more


Helius Medical Technologies to Exhibit at 2024 CMSC Annual Meeting, Marking a Year of Achievements: Making PoNS More Available to People with MS

NEWTOWN, Pa., May 23, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, will exhibit for the third consecutive year at the Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting, where it will spotlight a year of significant progress in making its innovative Portable Neuromodulation Stimulator... Read more


Inspire Medical Systems to Present at the Jefferies Global Healthcare Conference

MINNEAPOLIS, May 23, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024. Inspire is scheduled to present at 11:30 a.m. Eastern Time. The presentation will... Read more


Medtronic reports full year and fourth quarter fiscal 2024 financial results; announces dividend increase

Broad-based, durable growth across the company, including Cranial & Spinal Technologies, Diabetes, Cardiac Pacing, Surgical, and Structural Heart; gaining momentum as company enters new product cycles across many high-growth markets DUBLIN, May 23, 2024 /CNW/ -- Medtronic plc (NYSE:MDT) today announced financial results for its fourth quarter (Q4) and fiscal year 2024 (FY24), which ended April 26, 2024. Key Highlights Q4 revenue of $8.6 billion increased... Read more


Hyperfine to Present at the Jefferies Global Healthcare Conference

GUILFORD, Conn. / May 22, 2024 / Business Wire / Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced plans to present at the upcoming Jefferies Global Healthcare Conference, in New York, NY. Members of management are scheduled to present on Thursday, June 6, 2024, at 3:00 pm ET. A live webcast of... Read more


iRhythm Technologies to Present at the William Blair 44th Annual Growth Stock Conference

SAN FRANCISCO, May 22, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company will be participating in the upcoming William Blair 44th Annual Growth Stock Conference. iRhythm’s management is scheduled to present on Wednesday, June 5, at 11:20 a.m. Central Time. Interested parties may access a live and... Read more


Quanterix to Present at Leerink Partners Healthcare Crossroads Conference 2024

BILLERICA, Mass. / May 22, 2024 / Business Wire / Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will speak in a fireside chat at the 2024 Leerink Partners Healthcare Crossroads Conference. Quanterix’s presentation is scheduled for Wednesday, May 29, 2024, at 11:40 a.m. ET. The fireside chat will be made available to attendees and to the public... Read more


NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan

ELMSFORD, N.Y. / May 22, 2024 / Business Wire / NanoVibronix, Inc. (Nasdaq: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that the University of Michigan will begin the pilot phase of its clinical trial of UroShield this week. The “pilot” phase of the study is the first component of the broader study. As previously announced on November... Read more


CVRx to Present at the William Blair 44th Annual Growth Stock Conference

MINNEAPOLIS, May 22, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced that the management team will present at the William Blair 44th Annual Growth Stock Conference on Wednesday, June 5, 2024. The Company is scheduled to present at 8:40am Central Time the same day via webcast. A live audio webcast of the conference presentation will be available online at the investor relations page of the Company’s... Read more


MaxCyte Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development

ROCKVILLE, Md., May 22, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development, and commercialization of next-generation cell-based therapeutics and innovative bioprocessing applications, today announced it has entered into a strategic platform license (SPL) agreement with Legend Biotech, a global leader in cell therapy. Under the terms... Read more


EDAP TMS to Present at the Jefferies Global Healthcare Conference

LYON, France, May 22, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to deliver a presentation and host 1x1 investor meetings at the Jefferies Global Healthcare Conference, which is being held June 5-6, 2024, in New York City. Presentation details: Date: Wednesday, June 5th Time: 7:30 AM ET Webcast: /webcast/jeff302/... Read more


Repligen to Present at Upcoming June Investor Conferences

WALTHAM, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be presenting at the following June investor conferences. William Blair’s 44th Annual Growth Stock Conference being held in Chicago from June 4 – 6, 2024. Tony J. Hunt, Chief Executive Officer, is scheduled to present a company overview on June 5 at 12:00 p.m. CT. Jefferies’ Global... Read more


Therma Bright Announces up to $1,000,000 Unit Offering

Toronto, Ontario--(Newsfile Corp. - May 22, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer and partner in a wide-range of leading-edge, proprietary diagnostic and medical device technologies, announces that it proposes to undertake a non-brokered private placement of up to 100,000,000 units priced at $0.01 per unit for total proceeds of $1,000,000 (the "Offering"). Each unit will be comprised of one common share in the capital... Read more


Nyxoah Announces Proposed Offering of Ordinary Shares

Mont-Saint-Guibert, Belgium – May 22, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), announced today the commencement of a proposed underwritten public offering in the United States, which may include shares sold in a private offering to certain qualified or institutional... Read more


LeMaitre Vascular to Present at the Jefferies Global Healthcare Conference

BURLINGTON, Mass., May 21, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that George W. LeMaitre, Chairman & CEO, will present at the 2024 Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 11:00 AM ET at the Marriott Marquis in New York City. About LeMaitre LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people... Read more


Tactile Medical to Present at the William Blair 44th Annual Growth Stock Conference

MINNEAPOLIS, May 21, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the William Blair 44th Annual Growth Stock Conference, which is being held at the Loews Hotel in Chicago, IL from June 4th - 6th. Management will participate in a fireside chat on Tuesday, June 4th at... Read more


Modular Medical to Present at the Lytham Partners Spring 2024 Investor Conference on May 30

SAN DIEGO, CA / ACCESSWIRE / May 21, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2024 Investor Conference, taking place virtually on Thursday, May 30, 2024. Company... Read more


Merit Medical Systems Launches basixSKY™ Inflation Device

SOUTH JORDAN, Utah, May 21, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced the US commercial release of the basixSKY Inflation Device. BasixSKY is the latest addition to Merit’s comprehensive inflation device portfolio, which includes both digital and analog devices. The basixSKY is available as a standalone solution and in kits with Merit Angioplasty Packs, configured to offer complementing... Read more


AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18⁸⁵ System

Regulatory approval enables entry of AlphaVac Mechanical Thrombectomy System in European market LATHAM, N.Y. / May 21, 2024 / Business Wire / AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced European CE Mark approval of the AlphaVac F1885 System for the non-surgical... Read more


Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems

FREMONT, Calif., May 20, 2024 (GLOBE NEWSWIRE) -- Today Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, officially announced its Enhanced Small Particle (ESP™) Detection Option for its flagship Cytek Aurora™ and Cytek Northern Lights™ cell analysis systems. With this optional upgrade, these systems show superior sensitivity and resolution of subcellular materials, including extracellular vesicles (EVs), while maintaining high resolution... Read more


HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio

Southlake, Texas, May 20, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that it has been granted Indian Patent Application 201817014481 by the Indian Patent Office (IPO). To date, HeartSciences has been... Read more


IceCure Medical to Highlight Key Achievements and Provide Business Overview at A.G.P. / Alliance Global Partners' Virtual Healthcare Company Showcase

CAESAREA, Israel, May 20, 2024 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced the Company's CEO, Eyal Shamir, will present via a fireside chat at the A.G.P / Alliance Global Partners' Virtual Healthcare Company Showcase on Tuesday, May 21, 2024, at 8:20am EDT. Investors... Read more


Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 2024

SEATTLE, May 20, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today announced the Company will present information pertaining to the Company’s sponsored studies of its assets at the Society of Nuclear Medicine & Molecular Imaging (“SNMMI”) Annual Meeting 2024, which is... Read more


Boston Scientific: MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy Endpoints

Additional data from APPRAISE ATP trial reinforce modular therapy approach with EMBLEM™ Subcutaneous Implantable Defibrillator and EMPOWER™ Leadless Pacemaker MARLBOROUGH, Mass., May 18, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRM™ System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEM™ Subcutaneous... Read more


Medtronic Affera™ Mapping and Ablation System with Sphere-9™ Catheter achieves endpoints for safety and efficacy, providing promising evidence for the future of atrial fibrillation treatment

HRS late breaking data: SPHERE Per-AF trial demonstrates novel all-in-one system delivers exceptional results, plus increased efficiency and improved quality of life DUBLIN and BOSTON, May 17, 2024 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced positive results demonstrating excellent safety and efficacy of the Affera™ Mapping and Ablation System with Sphere-9™ Catheter, an all-in-one pulsed field (PF)... Read more


Medtronic: Late-breaking data show reliable performance of small-diameter defibrillation lead, the Medtronic OmniaSecure™

Global LEADR clinical trial meets safety and effectiveness objectives; results presented at Heart Rhythm 2024 and simultaneously published in Heart Rhythm DUBLIN and BOSTON, May 17, 2024 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced that its investigational OmniaSecure™ defibrillation lead met its primary safety and effectiveness endpoints, exceeding prespecified performance goals, in the global Lead Evaluation for... Read more


Innovative Fingerprint Drug Screening Solution Showcased at the UK's Premier Health and Safety Event

NEW YORK, May 17, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful exhibition of its Intelligent Fingerprinting Drug Screening Solution at The Health & Safety Event 2024, the United Kingdom’s largest annual technology showcase exhibiting products and services that strengthen and support workplace... Read more


Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia

IRVINE, Calif. / May 16, 2024 / Business Wire / Axonics, Inc. (Nasdaq: AXNX) today announced that it has received regulatory approval from the Therapeutic Goods Administration (TGA) for marketing the Axonics F15™ recharge-free sacral neuromodulation (SNM) system in Australia to treat adults with overactive bladder. “Approval of the Axonics recharge-free system is welcome news for Australians with bladder and bowel dysfunction,” said Dr. Ailsa Wilson Edwards, a urologist... Read more


Pulse Biosciences’ CellFX Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual Meeting

HAYWARD, Calif. / May 16, 2024 / Business Wire / Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced CellFX nsPFA technology will be featured in multiple presentations at the upcoming Heart Rhythm Society (HRS) 2024 Annual Meeting in Boston, MA from May 16-19. “We look forward to our proprietary CellFX nsPFA technology being highlighted in six total p... Read more


InMode to Present at Jefferies Healthcare Conference

YOKNEAM, Israel, May 16, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer and Spero Theodorou MD, Chief Medical Officer, will present in-person at the Jefferies Healthcare Conference in New York on June 5, 2024. The fireside chat, moderated by Matt Taylor, Managing Director, Senior Healthcare Analyst, is scheduled for 7:30 am Eastern Time on Wednesday,... Read more


EDAP TMS Reports First Quarter 2024 Financial Results

Strong Q1 2024 U.S. Focal One® HIFU procedure growth of +92% year-over-year Q1 2024 HIFU revenue of EUR 5.8 million ($6.3 million USD), an increase of 10.2% over Q1 2023 Q1 2024 total revenue of EUR 14.9 million ($16.1 million USD) increased 0.8% over Q1 2023 Company to host conference call and webcast today, May 16th, at 8:30 a.m. EDT LYON, France, May 16, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, reported today unaudited... Read more


Axogen Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®

ALACHUA, Fla. and TAMPA, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, is pleased to announce that it has initiated the rolling submission process with the U.S. Food and Drug Administration for a Biologics License Application (BLA) for licensure of Avance Nerve Graft® on May 15, 2024. “Today’s milestone represents a significant step in our... Read more


Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2024

Sales through new online portal increase 31% over the same period last year Gross margin for the first quarter of 2024 increases to 74.5% from 72.7% for the same period last year Reports steady progress on reimbursement strategy for the CompuFlo® Epidural System ROSELAND, N.J., May 16, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today... Read more


Ocumetics Technology Announces Offering of up to $4 million of Secured Convertible Debentures

Calgary, Alberta – TheNewswire - May 15, 2024.  Ocumetics Technology Corp. (“Ocumetics” or the “Corporation”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that it proposes to complete a non-brokered private placement of secured convertible debentures having an aggregate face value principal amount of up to $4,000,000 (the “Principal”).  The debentures will be subject to an original issue discount of 6%, resulting in net available funds to the... Read more


Quipt Home Medical Reports Second Quarter Fiscal 2024 Financial Results Posting Revenue Growth of 10% and Adjusted EBITDA Growth of 14%

• Posts Adjusted EBITDA Margin of 23.3% as a % of Revenue • Announced Normal Course Issuer Bid (“NCIB”) Subsequent to Quarter End CINCINNATI, May 15, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT; TSX: QIPT), a U.S.-based home medical equipment provider, focused on end-to-end respiratory care, today announced its second quarter fiscal 2024 financial results and operational highlights. These results pertain to the... Read more


Butterfly Network Enters the Bladder Scanning Market With First Specialty Product, iQ+ Bladder, in the United States

With iQ+ Bladder, Butterfly expands outside its core point-of-care ultrasound market to better serve the bladder scanning market with its proprietary Ultrasound-on-Chip™ technology. The bundled bladder solution includes an iQ+ Bladder probe, streamlined software, compact rolling cart, tablet and power splitter, paired with premium assembly. BURLINGTON, Mass. & NEW YORK / May 15, 2024 / Business Wire / Butterfly Network, Inc. (“Butterfly”, “the Company”)... Read more


Allurion Technologies Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight Loss

New data demonstrate significant fat mass loss while preserving lean mass NATICK, Mass. / May 15, 2024 / Business Wire / Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced three scientific presentations at the 31st European Congress on Obesity (ECO) held in Venice, Italy, on 12-15 May, 2024. Presentations include data from a study of 712 patients treated with the Allurion Program, which is anchored by the Allurion Balloon... Read more


TriSalus Life Sciences Reports Q1 2024 Financial Results and Business Update

Reported revenues of $6.5 million in 1Q24, up 116% compared to 1Q23 Reported gross margin of 85% in 1Q24 Secured up to $50 million of debt financing with OrbiMed to support TriNav® Infusion System growth initiatives Announced the appointment of Liselotte Hyveled to the Board of Directors Full year sales growth expected to exceed 50% Conference call May 15th at 9:00 a.m. EDT DENVER / May 15, 2024 / Business Wire / TriSalus Life Sciences Inc., (Nasdaq: TLSI), today... Read more


Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results

Continued progress enrolling in its VMT-α-NET and VMT01 clinical trials Disclosed a new internally discovered molecule that targets fibroblast activation protein-α Announced the in-licensing of a technology that enables the use of antibodies to direct radiolabeled ligands to tumor sites Raised $177.2 million in gross proceeds through various financing transactions and raised an additional $49.5 million subsequent to March 31st under our ATM Agreement. SEATTLE,... Read more


Merit Medical Executive Leadership Team Update

Joe Wright Appointed President Expands Deep Bench of Leadership Team Talent; Supports “Continued Growth Initiatives” Program SOUTH JORDAN, Utah, May 15, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced the appointment of Joe Wright as President, effective immediately. As President, Mr. Wright will be responsible for the oversight of Merit’s global commercial, marketing, and manufacturing... Read more


FONAR Announces Fiscal 2024 Financial Results for 3rd Quarter and Nine-Month Period

Total MRI scan volume at the HMCA-managed sites increased 11% to 154,790 scans for the nine-month period ended March 31, 2024 as compared to the nine-month period ended March 31, 2023. Net Income increased 25% to $12.5 million for the nine-month period ended March 31, 2024 as compared to the nine-month period ended March 31, 2023. Income from Operations for the nine-month period ended March 31, 2024 increased 24% to $15.2 million as compared to the nine-month... Read more


Xtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue Guidance

Expects Revenue for Full Year 2024 of $116 Million to $120 Million BELGRADE, MT / ACCESSWIRE / May 15, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Highlights Revenue of $27.9 million, up 55%, compared to the prior year quarter Gross... Read more

COPYRIGHT ©2023 HEALTH STOCKS HUB